Caremark Rx — AdvancePCS — Merger or Acquisition (September 2003)
26 slides from Caremark Rx's merger presentation, Sep 4, 2003
Slide 1: Caremark Rx and AdvancePCS Investor Presentation
% Caremark Rx, inc. AdvancePCS Investor Presentation a te, ey September 3, 2003 “ a -~
Slide 2: Link to
Link to searchable text of slide shown above
Slide 3: Agenda
‘ Agenda “ + Introduction + Transaction Overview + Industry Dynamics * Combination Benefits + Financial Overview + Q&A
Slide 4: Agenda
, Agenda — — + Introduction « Transaction Overview + Industry Dynamics * Combination Benefits + Financial Overview + Q&A
Slide 5: Key Transaction Terms
Key Transaction Terms Per share consideration: Value equivalent to 2.15 Caremark shares per AdvancePCS share Consideration mix: 90% stock / 10% cash Transaction value: $5.6 billion equity value, $5.8 billion enterprise value Transaction structure: Tax-free reorganization, excluding cash component Co
Slide 6: Executive Leadership
Executive Leadership Management Team + Mac Crawford, Chairman & Chief Executive Officer + A.D. Frazier, President & Chief Operating Officer + Howard McLure, EVP & Chief Financial Officer Board Composition + Existing Caremark board will be expanded to include three directors proposed by AdvancePCS
Slide 7: Agenda
, Agenda — — + Introduction + Transaction Overview + Industry Dynamics * Combination Benefits + Financial Overview + Q&A
Slide 8: Industry Trends
Industry Trends Total U.S. drug spend is growing at a rate of 14%, and is expected to account for 13% of U.S. healthcare expenditures by 2007* Increases in volume and price as well as a shift to higher cost drugs are driving drug spend growth Large number of brand drugs losing patent protection in f
Slide 9: Competitive Landscape
Competitive Landscape Many companies offer soiutions to control the rising cost of prescription drugs Pharmacy and Healthcare Cost ; Management 9 €3 AdvancePCs
Slide 10: Link to
Link to searchable text of slide shown above
Slide 11: Agenda
, Agenda — — + Introduction + Transaction Overview + Industry Dynamics * Combination Benefits + Financial Overview + Q&A
Slide 12: Strategic Benefits
Strategic Benefits ai + Enhanced provider of health management solutions + Highly complementary businesses » Increased customer diversity > Recognized expertise in mail service and retail programs. > Broader specialty programs » Comprehensive disease management solutions AdvancePCs + Expertise in dr
Slide 13: Link to
Link to searchable text of slide shown above
Slide 14: Link to
Link to searchable text of slide shown above
Slide 15: Link to
Link to searchable text of slide shown above
Slide 16: Link to
Link to searchable text of slide shown above
Slide 17: Link to
Link to searchable text of slide shown above
Slide 18: Link to
Link to searchable text of slide shown above
Slide 19: Agenda
‘ Agenda “ + Introduction + Transaction Overview + Industry Dynamics * Combination Benefits + Financial Overview + Q&A
Slide 20: Link to
Link to searchable text of slide shown above
Slide 21: Key Financials
Key Financials For the twelve months ended June 30, 2003 (In millions, except earnings per share) Caremark Rx AdvancePCS Net revenue $7,933 $14,680 EBITDA 489 387 Pre-tax income from continuing ops 407 300 Income from continuing operations* 244 181 Average shares outstanding 263 97 EPs* $0.93 $1.87
Slide 22: Key Financials (cont'd)
Key Financials (cont'd) As of June 30, 2003 (In millions, except ratios) Caremark Rx AdvancePCS Cash $526 $139 Debt 697 388 LTM EBITDA 489 387 LTM Interest expense, net 45 37 Debt / EBITDA 1.4Xx 1.0x Net debt / EBITDA 0.4x 0.6x EBITDA / Interest expense, net 10.9x 10.5x Souroe: Carematk Roc and Adva
Slide 23: Transaction Summary
Transaction Summary Enhanced provider of health management solutions Highly complementary businesses > Increased customer diversity with over 600 million prescriptions in the twelve months ended June 30, 2003 > Expanded distribution strengths > Broader specialty pharmaceutical and disease management
Slide 24: Strategic Summary
Strategic Summary Caremark, AdvancePCS and other PBMs play a vital role in the U.S. healthcare system by providing innovative pharmaceutical care programs that enhance the quality of life and health for consumers, while reducing cost. PBMs drive down pharmaceutical costs by employing sophisticated c
Slide 25: Link to
Link to searchable text of slide shown above
Slide 26: Forward Looking Statements
Forward Looking Statements Agenda Key Transaction Terms Executive Leadership Agenda Agenda Strategic Benefits Enhanced provider of health management solutions Highly complementary businesses Increased customer diversity Recognized expertise in mail service and retail programs Broader specialty progr